Sponsor or institution
Clinical trials and research at ArriVent BioPharma, Inc.
As of November 12, 2026, Find a Trial lists 3 clinical trials run by ArriVent BioPharma, Inc. that are recruiting, at sites in 17 countries (most in United States (3), China (2), Australia (1)). By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 17Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ARR-002 in advanced ovarian or endometrial cancer | Phase 1 | Orlando, Florida and 5 other locations | Recruiting | Aug 10, 2026 |
| Firmonertinib versus standard EGFR drugs as first treatment for advanced NSCLC with EGFR PACC mutations | Phase 3 | Fullerton, California and 140 other locations | Recruiting | Sep 22, 2025 |
| MRG007 (ARR-217) treatment for advanced solid tumors | Phase 1 | Los Angeles, California and 20 other locations | Recruiting | Jul 15, 2025 |
All recruiting trials (3)
-
ARR-002 in advanced ovarian or endometrial cancer
This phase 1 study tests ARR-002 to see if it is safe and tolerable in adults with advanced or metastatic ovarian or endometrial cancer who have limited treatment options.
-
Firmonertinib versus standard EGFR drugs as first treatment for advanced NSCLC with EGFR PACC mutations
This trial tests whether daily firmonertinib works better than standard EGFR drugs (osimertinib or afatinib) as the first treatment for people with advanced NSCLC that has EGFR PACC mutations.
-
MRG007 (ARR-217) treatment for advanced solid tumors
This trial will test MRG007 (ARR-217), an antibody-drug conjugate that targets CDH17, in adults with unresectable locally advanced or metastatic solid tumors who have exhausted standard therapies.
Quick answers
How many clinical trials run by ArriVent BioPharma, Inc. are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in United States (3 trials), China (2 trials), Australia (1 trial), Canada (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.